Gland Pharma reports 72% fall in Q4 consolidated net profit

19 May 2023 Evaluate

Gland Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported 72.30% fall in net profit at Rs 79.21 crore for the quarter under review as compared to Rs 285.98 crore for the same quarter in the previous year. Total income of the company decreased by 29.44% at Rs 824.36 crore for Q4FY23 as compared to Rs 1,168.25 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 72.48% fall in its net profit at Rs 78.68 crore for fourth quarter ended March 31, 2023 as compared to Rs 285.90 crore for the same quarter in the previous year. Total income of the company decreased by 29.47% at Rs 823.95 crore for Q4FY23 as compared to Rs 1,168.25 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported 36% fall in its net profit at Rs 775.83 crore as compared to Rs 1,212.16 crore for the previous year. Total income of the company decreased by 16.60% at Rs 3,856.99 crore for year under review as compared to Rs 4,624.65 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 35.54% fall in its net profit at Rs 781.04 crore as compared to Rs 1,211.66 crore for the previous year. Total income of the company decreased by 16.42% at Rs 3,865.06 crore for year under review as compared to Rs 4,624.65 crore for year ended March 31, 2022.

Gland Pharma Share Price

1802.20 23.05 (1.30%)
21-May-2024 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.00
Dr. Reddys Lab 5798.90
Cipla 1441.75
Zydus Lifesciences 1092.10
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.